In fact, in T2D both elevated plasma glucagon levels at fasting and defective inhibition of glucagon secretion in the postprandial state can be observed, related to an altered insulin suppression of the pancreatic alpha-cell glucagon exocytosis (7, 8). The gene discussed is INS; the disease is type 2 diabetes mellitus.